Upgrade to SI Premium - Free Trial

Moderna (MRNA) PT Raised to $32 at BofA Securities

May 1, 2026 10:25 AM
BofA Securities analyst Alec Stranahan raised the price target on Moderna (NASDAQ: MRNA) to $32.00 (from $31.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change